Aug 2026· Frontiers in Medicine· Vol 13· 0 citations· 94 references
Medicine
TL;DR
The functional roles of representative nanomaterials in pathogen POCT, including optical signal output, catalytic signal amplification, target enrichment, and interfacial regulation are summarized, and their applications in respiratory, urinary, and fecal specimens are discussed.
Abstract
Nanomaterials, with their unique physicochemical properties, have emerged as important enabling components for improving the performance of point-of-care testing (POCT) technologies for pathogen detection. Many conventional POCT methods still face challenges in sensitivity, specificity, multiplexing capability, and quantitative accuracy, particularly when applied to low-abundance pathogens in complex clinical samples. This review first summarizes the functional roles of representative nanomaterials in pathogen POCT, including optical signal output, catalytic signal amplification, target enrichment, and interfacial regulation. We then discuss how these materials improve lateral flow assays, biosensors, microfluidic systems, and isothermal nucleic acid amplification platforms. Finally, we summarize three major nanomaterial-assisted recognition mechanisms, including pathogen surface recognition, ROS-mediated signal conversion, and nucleic acid recognition, and discuss their applications in respiratory, urinary, and fecal specimens. These advances are expected to support the development of more sensitive, integrated, and field-deployable diagnostic systems for infectious disease control.
Bloodstream infection (BSI) is a life-threatening systemic disease with rapid onset and high mortality, which calls for rapid and accurate pathogen detection for precision medical care. Conventional diagnostic methods, including blood culture, molecular assays, and mass spectrometry, remain limited by long turnaround t...
Heng Zhang, Meng-Qi Bai, Jing-Wen Wang et al.· ACS Omega· 0 citations
Infectious diseases caused by bacteria, viruses, fungi, and parasites continue to impose substantial global health burdens, particularly in low- and middle-income countries. Accurate and timely diagnosis remains essential for appropriate treatment, transmission control, and outbreak management. Although conventional di...
F. Osazuwa, G. Iyare, H. H. Y. Muhammad-Sani· Scientific African· 0 citations
Nanotechnology has brought transformative advancements across numerous sectors, particularly in medicine. One of its most impactful applications lies in biomedical diagnostics, where the development of nanosensors has significantly enhanced the detec-tion and identification of disease-related biomarkers.
These nano...
J. Dash, G. Pattnaik, Subhranshu Acharya et al.· Current Drug Therapy· 0 citations
Rapid and accurate detection of pathogens is critical for clinical diagnosis, environmental monitoring, public health and food safety. Conventional diagnostic methods, such as culture-based, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR), are well established and widely used due to their...
Parin Singhal, Shivaji Misra, A. Prakash et al.· Journal of Microbiological M...· 0 citations
Hepatitis B virus (HBV) infection remains a major global health challenge, requiring accurate diagnostic tools and precise therapeutic drug monitoring (TDM) to guide antiviral treatment and prevent disease progression. Conventional laboratory‑based assays, while reliable, are often limited by long turnaround times, hig...
Mosquito-borne viruses, including dengue, Zika and chikungunya viruses, place a substantial burden on diagnostic services, especially where molecular laboratories are inaccessible or slow to return results. Point-of-care biosensors could reduce turnaround times and bring testing closer to patients in primary care, outb...
Er-Kang Bian, Ruo-Hang Wang, Kun Yin et al.· Biosensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.